| scholarly article | Q13442814 |
| P50 | author | Karin von Wachenfeldt | Q57321634 |
| P2093 | author name string | Ilhem Messaoudi | |
| Xiumin Li | |||
| Amrita Kamath | |||
| Kevin L Grove | |||
| Paul Kievit | |||
| Nicholas van Bruggen | |||
| Kyra J Cowan | |||
| Stuart Bunting | |||
| Lindsay Bader | |||
| Shijie Li | |||
| Sherry Bullens | |||
| Ganesh Kolumam | |||
| Björn Frendéus | |||
| Anna-Karin Robertson | |||
| Christine Valfridsson | |||
| P2860 | cites work | RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides | Q22010236 |
| Obesity, Inflammation, and Insulin Resistance | Q22250939 | ||
| Inflammation, stress, and diabetes | Q24523336 | ||
| Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance | Q24617743 | ||
| Variations in DNA elucidate molecular networks that cause disease | Q24622333 | ||
| Exploring the full spectrum of macrophage activation | Q24653754 | ||
| Delay of T cell senescence by caloric restriction in aged long-lived nonhuman primates | Q24677451 | ||
| Stimulatory and inhibitory signals originating from the macrophage Fcgamma receptors | Q28204968 | ||
| Fc receptors and immunoglobulin binding factors | Q28307392 | ||
| p38 MAPK signalling cascades in inflammatory disease | Q28678986 | ||
| The chemokine system in diverse forms of macrophage activation and polarization | Q29547719 | ||
| IKK-beta links inflammation to obesity-induced insulin resistance | Q29614285 | ||
| Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance | Q29614354 | ||
| Genetics of gene expression and its effect on disease | Q29614591 | ||
| CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity | Q29617380 | ||
| Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters | Q29617381 | ||
| Inflammatory mechanisms in obesity | Q29617932 | ||
| CCR2 modulates inflammatory and metabolic effects of high-fat feeding | Q29622869 | ||
| The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus | Q30379006 | ||
| The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: II. Therapeutic management of atherogenic dyslipidemia. | Q30380628 | ||
| Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice | Q30444108 | ||
| Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis | Q33207408 | ||
| Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies | Q33337548 | ||
| The metabolic syndrome | Q33569142 | ||
| Lipid-induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL. | Q33719103 | ||
| Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins | Q33834184 | ||
| Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis | Q34620005 | ||
| The macrophage foam cell as a target for therapeutic intervention | Q34986351 | ||
| Normalization of obesity-associated insulin resistance through immunotherapy | Q34994222 | ||
| The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial | Q35111527 | ||
| Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study | Q35717014 | ||
| Expression of interleukin-15 in mouse and human atherosclerotic lesions | Q35747016 | ||
| Markers of inflammation and their clinical significance | Q36095131 | ||
| Adipose tissue, adipokines, and inflammation | Q36114223 | ||
| MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits | Q36273853 | ||
| Adiponectin induces pro-inflammatory programs in human macrophages and CD4+ T cells | Q36347695 | ||
| Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models | Q36366126 | ||
| Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes | Q36842628 | ||
| Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome | Q36925959 | ||
| Improved insulin sensitivity despite increased visceral adiposity in mice deficient for the immune cell transcription factor T-bet | Q36938197 | ||
| Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice | Q37031087 | ||
| Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates | Q37073698 | ||
| Early-onset Type 2 diabetes mellitus: an increasing phenomenon of elevated cardiovascular risk | Q37104861 | ||
| Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. | Q37111330 | ||
| Optimal window of caloric restriction onset limits its beneficial impact on T-cell senescence in primates | Q37137596 | ||
| Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. | Q37466109 | ||
| Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein | Q37531625 | ||
| Chemokines as immune mediators of liver diseases related to the metabolic syndrome | Q37749336 | ||
| Toll-like receptor-dependent lipid body formation in macrophage foam cell formation. | Q37774222 | ||
| Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease | Q37827887 | ||
| The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance | Q37974553 | ||
| Adaptive immunity in obesity and insulin resistance | Q38030832 | ||
| C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin. | Q39886203 | ||
| Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages | Q40043923 | ||
| Interactions of plasma lipoproteins with endothelial cells | Q40134272 | ||
| Anti-OxLDL IgG blocks OxLDL interaction with CD36, but promotes FcgammaR, CD32A-dependent inflammatory cell adhesion | Q40212791 | ||
| Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population | Q40402572 | ||
| The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages | Q40611945 | ||
| Inflamed fat: what starts the fire? | Q40899161 | ||
| Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins | Q42083643 | ||
| Getting away from glucose: fanning the flames of obesity-induced inflammation | Q42110382 | ||
| Sex hormone-binding globulin: a new marker of disease severity and prognosis in men with chronic heart failure | Q43206246 | ||
| Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis | Q44370996 | ||
| Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults | Q45027927 | ||
| Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes | Q45142800 | ||
| Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity | Q45251877 | ||
| Inflammatory markers in women with a recent history of gestational diabetes mellitus | Q46426580 | ||
| Increased plasma S100A12 (EN-RAGE) levels in hemodialysis patients with atherosclerosis | Q46458183 | ||
| Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus | Q46795016 | ||
| Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice | Q46859383 | ||
| High density lipoproteins downregulate basic fibroblast growth factor production and release in minimally oxidated-LDL treated smooth muscle cells. | Q51266255 | ||
| Endothelin-1 induces contraction via a Syk-mediated p38 mitogen-activated protein kinase pathway in rat aortic smooth muscle. | Q53573920 | ||
| Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis. | Q54336014 | ||
| Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice. | Q54463267 | ||
| Syk Is Required for p38 Activation and G2/M Arrest in B Cells Exposed to Oxidative Stress | Q58034553 | ||
| Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice | Q62735862 | ||
| Oxidized low density lipoprotein and very low density lipoprotein enhance expression of monocyte chemoattractant protein-1 in rabbit peritoneal exudate macrophages | Q73589896 | ||
| Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells | Q73783188 | ||
| Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications | Q74440973 | ||
| Oxidized LDL in carotid plaques and plasma associates with plaque instability | Q78366337 | ||
| GM-CSF deficiency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoE-deficient mice | Q80012075 | ||
| Inflammation and obesity: STAMPing out insulin resistance? | Q80657413 | ||
| Possible new role of monocyte chemoattractant protein-1 in hemodialysis patients with cardiovascular disease | Q81219253 | ||
| Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity | Q81272522 | ||
| Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions | Q83198102 | ||
| Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall | Q85054596 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P921 | main subject | obesity | Q12174 |
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 256-269 | |
| P577 | publication date | 2013-06-11 | |
| P1433 | published in | Molecular Metabolism | Q27724805 |
| P1476 | title | Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques | |
| P478 | volume | 2 |
| Q37709623 | Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases |
| Q42557137 | Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA |
| Q42382317 | Can Antibodies Protect Us Against Cardiovascular Disease? |
| Q49072554 | Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus. |
| Q96685924 | Developing a vaccine against atherosclerosis |
| Q55404051 | Diet-Induced Abdominal Obesity, Metabolic Changes, and Atherosclerosis in Hypercholesterolemic Minipigs. |
| Q30389395 | Effects of hyperandrogenemia and increased adiposity on reproductive and metabolic parameters in young adult female monkeys |
| Q88678430 | Obesity as an immune-modifying factor in cancer immunotherapy |
| Q34169104 | Oxidized low density lipoprotein and total antioxidant capacity in type-2 diabetic and impaired glucose tolerance Saudi men. |
| Q39432694 | Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action |
| Q28553042 | Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect |
| Q46036092 | Use and Importance of Nonhuman Primates in Metabolic Disease Research: Current State of the Field. |
| Q36279562 | Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis |
| Q37747331 | oxLDL antibody inhibits MCP-1 release in monocytes/macrophages by regulating Ca2+ /K+ channel flow |
Search more.